186 related articles for article (PubMed ID: 10918529)
1. Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats.
Picard F; Deshaies Y; Lalonde J; Samson P; Labrie C; Bélanger A; Labrie F; Richard D
Int J Obes Relat Metab Disord; 2000 Jul; 24(7):830-40. PubMed ID: 10918529
[TBL] [Abstract][Full Text] [Related]
2. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity.
Lemieux C; Picard F; Labrie F; Richard D; Deshaies Y
Obes Res; 2003 Mar; 11(3):477-90. PubMed ID: 12634448
[TBL] [Abstract][Full Text] [Related]
3. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats.
Goss PE; Qi S; Cheung AM; Hu H; Mendes M; Pritzker KP
J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):79-87. PubMed ID: 15544933
[TBL] [Abstract][Full Text] [Related]
4. Hypocholesterolemic action of the selective estrogen receptor modulator acolbifene in intact and ovariectomized rats with diet-induced hypercholesterolemia.
Lemieux C; Gélinas Y; Lalonde J; Labrie F; Richard D; Deshaies Y
Metabolism; 2006 May; 55(5):605-13. PubMed ID: 16631436
[TBL] [Abstract][Full Text] [Related]
5. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with the antiestrogen EM-652.HCl on pituitary estrogen receptor alpha and prolactin mRNA expression in intact, ovariectomized and gonadotropin-releasing hormone-treated female rats.
Pelletier G; El-Alfy M; Labrie C; Martel C; Labrie F
Neuroendocrinology; 2001 Dec; 74(6):367-74. PubMed ID: 11752893
[TBL] [Abstract][Full Text] [Related]
7. Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
Sutherland MK; Brady H; Gayo-Fung LM; Leisten J; Lipps SG; McKie JA; O'Leary E; Patnaik N; Anderson DW; Bhagwat SS; Stein B
Calcif Tissue Int; 2003 Jun; 72(6):710-6. PubMed ID: 14563000
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
Frolik CA; Bryant HU; Black EC; Magee DE; Chandrasekhar S
Bone; 1996 Jun; 18(6):621-7. PubMed ID: 8806005
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
[TBL] [Abstract][Full Text] [Related]
10. Interaction of corticosterone and gonadal steroids on lipid deposition in the female rat.
Deshaies Y; Dagnault A; Lalonde J; Richard D
Am J Physiol; 1997 Aug; 273(2 Pt 1):E355-62. PubMed ID: 9277389
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats.
Meli R; Pacilio M; Raso GM; Esposito E; Coppola A; Nasti A; Di Carlo C; Nappi C; Di Carlo R
Endocrinology; 2004 Jul; 145(7):3115-21. PubMed ID: 15059958
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
Ke HZ; Chen HK; Simmons HA; Qi H; Crawford DT; Pirie CM; Chidsey-Frink KL; Ma YF; Jee WS; Thompson DD
Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
[TBL] [Abstract][Full Text] [Related]
13. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
[TBL] [Abstract][Full Text] [Related]
14. Supplementing with Opuntia ficus-indica Mill and Dioscorea nipponica Makino extracts synergistically attenuates menopausal symptoms in estrogen-deficient rats.
Ko BS; Lee HW; Kim DS; Kang S; Ryuk JA; Park S
J Ethnopharmacol; 2014 Aug; 155(1):267-76. PubMed ID: 24875644
[TBL] [Abstract][Full Text] [Related]
15. Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function.
Liu ML; Xu X; Rang WQ; Li YJ; Song HP
Int J Cardiol; 2004 Dec; 97(3):485-93. PubMed ID: 15561337
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Li S; Lévesque C; Geng CS; Yan X; Labrie F
Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
[TBL] [Abstract][Full Text] [Related]
17. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
18. Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat.
Martel C; Picard S; Richard V; Bélanger A; Labrie C; Labrie F
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):45-56. PubMed ID: 11074355
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice.
Zeitlin L; Segev E; Fried A; Wientroub S
J Cell Biochem; 2003 Oct; 90(2):347-60. PubMed ID: 14505351
[TBL] [Abstract][Full Text] [Related]
20. Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats.
Choi JS; Song J
Nutrition; 2009 Jun; 25(6):676-85. PubMed ID: 19230619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
